Home › OncoGenex's pancreatic cancer drug found ineffective in study
 

Keywords :   


OncoGenex's pancreatic cancer drug found ineffective in study

2015-09-23 20:07:41| Biotech - Topix.net

REUTERS: Drug developer OncoGenex Pharmaceuticals Inc said its experimental combination therapy for pancreatic cancer was not effective in a mid-stage study. The intravenous drug, apatorsen, when added to Celgene Corp's combination treatment of Abraxane and chemotherapy drug gemcitabine, did not show any survival benefit when compared with the Abraxane combination alone, OncoGenex said.

Tags: found study drug cancer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
24.115 2 PG
24.11215103TW 17svtw
24.11 Switch light
24.11Dr.SLUMP 19
24.11layover LP
24.11PING i230 6W 5
24.11BTS CD
24.11HG 56
More »